Life sciences news

flanders.bio has relocated!

Monday September 5th 2022

Read more
Nieuwe investering voor HERAN Partners: Aspect Analytics

Monday September 5th 2022

Read more
Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology

Friday September 2nd 2022

Read more
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients

Thursday September 1st 2022

Read more
reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration

Wednesday August 31st 2022

Read more
Autoimmune disorders increase risk of cardiovascular disease

Saturday August 27th 2022

Read more
Biocartis obtains ISO 27001 certification for information security management

Thursday August 25th 2022

Read more
Alexandra Clyde appointed to Sequana Medical Board of Directors

Thursday August 25th 2022

Read more
Your news here?

Become a flanders.bio member
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Thursday August 25th 2022

Read more
mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA

Tuesday August 23rd 2022

Read more
argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis

Thursday August 11th 2022

Read more

More info?

Communication Coordinator